Vis enkel innførsel

dc.contributor.authorHenning, Oliver Johannes
dc.contributor.authorLossius, Morten
dc.contributor.authorLima, Maren Haugen
dc.contributor.authorMevåg, Morten Andreas
dc.contributor.authorVillagran, Antonia
dc.contributor.authorNakken, Karl Otto
dc.contributor.authorLandmark, Cecilie Johannessen
dc.date.accessioned2019-11-12T11:15:32Z
dc.date.accessioned2019-11-13T10:21:23Z
dc.date.available2019-11-12T11:15:32Z
dc.date.available2019-11-13T10:21:23Z
dc.date.issued2019-10-28
dc.identifier.citationHenning Oj, Lossius M, Lima MH, Mevåg MA, Villagran A, Nakken Ko, Landmark CJL. Refractory epilepsy and nonadherence to drug treatment. Epilepsia Open. 2019:1-6en
dc.identifier.issn2470-9239
dc.identifier.issn2470-9239
dc.identifier.urihttps://hdl.handle.net/10642/7826
dc.description.abstractIn patients with epilepsy, nonadherence to agreed antiepileptic drug (AED) treatment may result in seizure relapse, and at worst sudden unexpected death. The aim of this study was to examine the extent of both unintentional and intentional nonadherence among Norwegian patients with refractory epilepsy and try to identify possible risk factors. At the National Centre for Epilepsy in Norway, 333 consecutive adult in‐ and outpatients with refractory epilepsy participated in an anonymous survey about adherence to drug treatment. Twenty‐two percentages admitted that they sometimes or often forgot to take their drugs as scheduled, and 19% reported that they, rarely, sometimes or often intentionally did not follow the AED treatment plan agreed upon with their physician. Young age and depression were significantly correlated with unintentional nonadherence. Intentional nonadherence was associated with young age (36 years or younger). We found nonadherence not to be associated with any specific AED. In conclusion, about one‐fifth of patients with refractory epilepsy admitted that they did not adhere to the agreed drug treatment plan, either intentionally or unintentionally. Measures to reduce nonadherence in this patient group may improve seizure control and should be tailored to address both unintentional and intentional lack of adherence.en
dc.language.isoenen
dc.publisherWileyen
dc.relation.ispartofseriesEpilepsia Open;Volume 4, Issue 4,December 2019
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2019 The Authors.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAdherenceen
dc.subjectDrug treatmentsen
dc.subjectEpilepsyen
dc.subjectRefractoriesen
dc.titleRefractory epilepsy and nonadherence to drug treatmenten
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2019-11-12T11:15:32Z
dc.description.versionpublishedVersionen
dc.identifier.doihttps://dx.doi.org/10.1002/epi4.12367
dc.identifier.cristin1746455
dc.source.journalEpilepsia Open


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2019 The Authors.
Med mindre annet er angitt, så er denne innførselen lisensiert som This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2019 The Authors.